021-5137-0935
sales@aqbiopharma.com.cn
Yangzhou Fluoropharma Technology Co., Ltd. was founded in 2011 by a team including winners of the Second Prize of the National Natural Science Award, Jiangsu Provincial Double Innovation Talents and multiple overseas-returned PhDs. It is a professional fluorinated pharmaceutical technology enterprise in China.
The company focuses on the R&D of fluorinated pharmaceutical products and corresponding process technologies, covering new fluorinated drugs and their intermediates. Our products and technologies cover all stages of the pharmaceutical value chain: preclinical new drug research, Phase I, II and III clinical trials, and commercialized marketed products. We specialize in the R&D, production, sales and technology licensing of new fluorinated drug scaffolds featuring rare heterocyclic structures.
Our core mature R&D products feature proprietary technical advantages. For the R&D and manufacturing of fluorinated pharmaceuticals, we adopt self-developed fluorinated building block technology to replace traditional fluorination techniques, enabling industrialized production and strengthening our market competitiveness. We currently hold a number of core patented technologies.
Our short and medium-term goal is to continuously develop internationally competitive fluorinated pharmaceutical products and technologies to expand market share. Our long-term goal lies in the research and development of fluorine-based generic drugs and novel fluorinated drugs.
